The race for releasing a viable COVID-19 vaccine intensified in the past couple of weeks. After Pfizer and BioNTech, Moderna also filed for approval in the UK and the US, countries increase their dose orders.
According to Moderna, the Canadian government doubled its order for its COVID-19 vaccine candidate. If the country initially ordered 20 million doses, it has now exercised its option to order 20 million more doses. Overall, the government will benefit from 40 million doses. The doses will come from Moderna’s site in Europe.
Despite the increase, Moderna stated that it is on track with its start date of shipping mRNA-1273 later on this month, if approved by regulators.
Following the news, the company’s stock price traded 1.3% higher. In the last quarter, Moderna stock price is up more than 146%, while USA500 added 7.8%.